The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study

<i>Background and Objectives:</i> This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are unsuitable for standard induction thera...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Changcheng Zheng
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-01-01
Serie:	Medicina
Soggetti:	acute myeloid leukemia elderly patients low intensity chemotherapy hypomethylating agents complete remission survival
Accesso online:	https://www.mdpi.com/1648-9144/59/1/114
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!